title: Is programmed cell death ligand-1 expression required for optimal response to anti-PD-1 antibody in cancer.
authors: Ankara Numune Education and Research Hospital, Department of Medical Oncology, Ankara, Turkey.
authors: Mehmet A N
authors: MA
authors: Sendur
authors: Sercan
authors: S
authors: Aksoy
authors: Nuriye
authors: N
authors: Yildirim Ozdemir
authors: Muhammed B
authors: MB
authors: Akinci
authors: Nurullah
authors: N
authors: Zengin
authors: Kadri
authors: K
authors: Altundag
mesh_terms: D000906:Antibodies / Q000627:therapeutic use*; D060890:B7-H1 Antigen / Q000032:analysis / Q000502:physiology*; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*; D061026:Programmed Cell Death 1 Receptor / Q000037:antagonists & inhibitors*
chemical_list: D000906:Antibodies; D060890:B7-H1 Antigen; C423236:CD274 protein, human; C105992:PDCD1 protein, human; D061026:Programmed Cell Death 1 Receptor